Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.12 | N/A |
| PEG Ratio (TTM) | 0.10 | N/A |
| P/S Ratio (TTM) | 0.74 | N/A |
| P/B Ratio (TTM) | 3.41 | N/A |
| P/FCF Ratio (TTM) | 12.60 | N/A |
| Price to 5YR AVG Earnings Ratio | 20.83 | N/A |
| Price to 5YR AVG FCF Ratio | 10.85 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.74% | N/A |
| ROE (TTM) | 17.87% | N/A |
| Net Profit Margin (TTM) | 4.11% | N/A |
| ROIC 5YR AVG | 12.52% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.33% | 16.37% | 25.47% |
| Revenue | 1.28% | 17.44% | 10.63% |
| Net Income | 18.86% | 29.99% | 31.46% |
| Cash Flow | 15.59% | 60.79% | 31.90% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.87 | N/A |
| Quick Ratio (TTM) | 0.87 | N/A |
| D/E Ratio (TTM) | 0.25 | N/A |
| Interest Coverage (TTM) | 4.20 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.98 | N/A |
| LTL to 5YR AVG FCF | 4.33 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.04% | N/A |